The HLA-B27 PCR test detects the presence of the HLA-B27 gene using polymerase chain reaction (PCR). HLA-B27 is a genetic marker associated with certain autoimmune diseases, particularly ankylosing spondylitis (AS) and other seronegative spondyloarthropathies.
✅ Diagnosing Ankylosing Spondylitis (AS) – A chronic inflammatory arthritis affecting the spine and sacroiliac joints.
✅ Identifying Other Spondyloarthropathies, including:
| Result | Interpretation |
|---|---|
| Positive (+) | HLA-B27 gene is present; higher risk of spondyloarthropathies but does not confirm disease. |
| Negative (-) | HLA-B27 gene is absent; does not rule out the disease, but lowers the likelihood. |
🔹 HLA-B27 is present in ~90% of people with ankylosing spondylitis, but not all individuals with HLA-B27 will develop the disease.
| Disease | HLA-B27 Positive Rate |
|---|---|
| Ankylosing Spondylitis (AS) | 80–95% |
| Reactive Arthritis (ReA) | 50–80% |
| Psoriatic Arthritis (PsA) | 20–50% |
| Enteropathic Arthritis (IBD-Associated Arthritis) | 30–50% |
| Juvenile Idiopathic Arthritis (JIA, Enthesitis-related) | 50–85% |
📌 Important: Having HLA-B27 does not mean you will develop a disease, just that your risk is higher.
| Test | Purpose | Use Case |
|---|---|---|
| HLA-B27 PCR | Detects genetic predisposition | Helps diagnose autoimmune diseases |
| ESR & CRP | Measures inflammation | Active inflammation in arthritis |
| X-ray / MRI (Sacroiliac Joints & Spine) | Detects joint damage | Confirms ankylosing spondylitis |
| Rheumatoid Factor (RF) & Anti-CCP | Rules out rheumatoid arthritis | Negative in HLA-B27 diseases |
✔ HLA-B27 is a genetic marker linked to ankylosing spondylitis & other autoimmune diseases.
✔ A positive test does not confirm disease; symptoms & imaging are needed for diagnosis.
✔ It is useful for risk assessment, family screening, and supporting clinical evaluation.
✔ Additional inflammatory markers & imaging are needed for a full diagnosis.
₹1,800.00 Original price was: ₹1,800.00.₹1,399.00Current price is: ₹1,399.00.